OpenBilldrug price receipt

NADAC week of 2026-10-14

JATENZO 158 MG CAPSULE

FDA nonproprietary name: testosterone undecanoate

For 30 capsules

Pharmacies pay

$269.16 filed

30 × $8.97187 per EA

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

Medicare Part D paid

$396.03 filed

30 × $13.20103 per EA, Part D average

Medicare's price is not your price.

Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18


The spread

1.5× estimated

Medicare paid 1.5× what pharmacies pay.

Part D averages every strength and form sold under “Jatenzo” / “Testosterone Undecanoate” into one figure, so it is not specific to this NDC.

OpenBill calculation · DSD_PTD_RY26_P04_V10_DY24_BGM.csv + nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17) · Part D 2024-01-01 to 2024-12-31 (file of 2026-06-25, retrieved 2026-10-18)

Cost-plus estimate

$314.53 estimated

$269.16 + $40.37 (15%) + $5.00 fee per fill = $314.53

This is a model, not a price any pharmacy quoted. Shipping is not included. How it is worked out

OpenBill calculation · nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17)

Open the interactive card Change the quantity, type what you were charged, and see every record in full.

What it is

JATENZO 158 MG CAPSULE is how the CMS NADAC file names this product. The FDA NDC Directory lists it as testosterone undecanoate, under the trade name “Jatenzo”.

FDA gives its dosage form as capsule, liquid filled and its route as oral.

The labeler, the company named on the label, is TOLMAR Inc.

FDA’s Established Pharmacologic Class for it is Androgen.

The NADAC file of 2026-10-14 prices it under one NDC (National Drug Code), 69087-0158-12.

NADAC classes it as a brand-name drug (rate-setting class B), and does not mark it as sold over the counter.

What pharmacies pay

Pharmacies pay $269.16 for 30 capsules (30 × $8.97187 per EA, rounded to the cent), by the CMS NADAC file of 2026-10-14; that price took effect on 2026-09-23. That is what pharmacies pay their suppliers, not what they charge you.

NADAC’s explanation code for it: 1, calculated from the most recently completed pharmacy survey.

The NDC

Other strengths, forms and brands

3 other products in the NADAC file share the FDA nonproprietary name testosterone undecanoate with JATENZO 158 MG CAPSULE.

ProductPharmacies pay per unitMedicare per unit
JATENZO 158 MG CAPSULE this page
brand · capsule, liquid filled
$8.97187 per EA filed
eff. 2026-09-23
$13.20103 per EA filed
Part D 2024 average
JATENZO 198 MG CAPSULE
brand · capsule, liquid filled
$8.9534 per EA filed
eff. 2026-09-23
$13.20103 per EA filed
Part D 2024 average
JATENZO 237 MG CAPSULE
brand · capsule, liquid filled
$17.93094 per EA filed
eff. 2026-09-23
$13.20103 per EA filed
Part D 2024 average
TLANDO 112.5 MG CAPSULE
brand · capsule, liquid filled
$7.16533 per EA filed
eff. 2026-09-23
$6.00661 per EA filed
Part D 2024 average

Part D is one average per brand and generic name, over every strength and form.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18

Compared with its class

Its NADAC price is $8.97187 per EA filed.

Of the 6 other products in FDA’s Androgen class priced per EA, 1 has a higher middle NADAC price and 5 a lower one. The one in the middle is DANAZOL 200 MG CAPSULE, at $2.65221 per EA filed (eff. 2026-09-23).

Prices are compared per unit, whatever the strength or dose, and a class is not a list of substitutes.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

What Medicare paid

Medicare Part D paid $396.03 for 30 capsules, at an average of $13.20103 per EA in 2024 (2024-01-01 to 2024-12-31) for “Jatenzo” and “Testosterone Undecanoate”, every strength and form sold under that name together (Medicare Part D Spending by Drug, file of 2026-06-25).

That average covers 7,521 Part D claims (fills, including refills) for 2024-01-01 to 2024-12-31, across every maker, strength and form under the name.

Medicare's price is not your price.

What to ask at the counter

None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.

Questions

Why is the comparison with Medicare for JATENZO 158 MG CAPSULE labelled estimated?
Beyond what the card shows, the records give these reasons: The Part D figure covers 2024-01-01 to 2024-12-31; the NADAC price is from the file of 2026-10-14. Part D spending basis, as the Part D record states it: Part D 2024 average spend per dosage unit for Jatenzo / Testosterone Undecanoate: all makers, strengths, forms and routes combined, claim-weighted; gross cost incl. dispensing fees and patient pay, before rebates. Unit taken as NADAC's EA. Joined on brand name.